Sophia Randolph
Chief Tech/Sci/R&D Officer en ALX ONCOLOGY HOLDINGS INC. .
Fortuna: 4 M $ al 31/03/2024
Perfil
Sophia Randolph is currently the Director & Chief Medical Officer at ALX Oncology Holdings, Inc. She previously worked as the Director-Clinical Sciences & Oncology at Merck & Co., Inc. from 2007 to 2008 and as the Executive Director-Oncology at Pfizer Inc. from 2015 to 2016.
Dr. Randolph completed her undergraduate degree at Harvard University and obtained a doctorate from the University of Michigan.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/02/2024 | 342 349 ( 0.68% ) | 4 M $ | 31/03/2024 |
Cargos activos de Sophia Randolph
| Empresas | Cargo | Inicio |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 01/06/2016 |
Antiguos cargos conocidos de Sophia Randolph.
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/04/2016 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/05/2008 |
Formación de Sophia Randolph.
| Harvard University | Undergraduate Degree |
| University of Michigan | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
- Bolsa de valores
- Insiders
- Sophia Randolph
